Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway

Journal of Immunology

Volumn 169, Issue 7, 2002, Pages 3926-3933

  Procópio, Daniela O ^a   Almeida, Igor C ^a   Torrecilhas, Ana Cláudia T ^a   Cardoso, Jarbas E ^a   Teyton, Luc ^a   Travassos, Luiz R ^a   Bendelac, Albert ^a   Gazzinelli, Ricardo T ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; GLYCOPROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MUCIN;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CHEMOLUMINESCENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; TRYPANOSOMA CRUZI;

EID: 0036785644     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.7.3926     Document Type: Article

References (62)

1. Porcelli, S. A. 1995. The CD1 family: a third lineage of antigen-presenting molecules. Adv. Immunol. 59:1.
2. Park, S. H., and A. Bendelac. 2000. CD1-restricted T-cell responses and microbial infection. Nature 406:788.
3. Calabi, F., J. M. Jarvis, L. H. Martin, and C. Milstein. 1989. Two classes of CD1 genes. Eur. J. Immunol. 19:285.
4. Balk, S. P., P. A. Bleicher, and C. Terhorst. 1991. Isolation and expression of cDNA encoding the murine homologues of CD1. J. Immunol. 146:768.
5. Chiu, Y. H., J. Jayawardena, A. Weiss, D. Lee, S. H. Park, A. Dautry-Varsat, and A. Bendelac. 1999. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. Med. 189:103.
6. Sugita, M., R. M. Jackman, E. van Donselaar, S. M. Behar, R. A. Rogers, P. J. Peters, M. B. Brenner, and S. A. Porcelli. 1996. Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs. Science 273:349.
7. Hanau, D., D. Fricker, T. Bieber, M. E. Esposito-Farese, H. Bausinger, J. P. Cazenave, L. Donato, M. M. Tongio, and H. de la Salle. 1994. CD1 expression is not affected by human peptide transporter deficiency. Hum. Immunol. 41:61.
8. 2-microglobulin-dependent surface expression of functional mouse CD1. 1. J. Exp. Med. 182:1913.
9. + T cells. Nature 372:691.
10. Sieling, P. A., D. Chatterjee, S. A. Porcelli, T. I. Prigozy, R. J. Mazzaccaro, T. Soriano, B. R. Bloom, M. B. Brenner, M. Kronenberg, P. J. Brennan, et al. 1995. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269:227.
11. Beckman, E. M., A. Melian, S. M. Behar, P. A. Sieling, D. Chatterjee, S. T. Furlong, R. Matsumoto, J. P. Rosat, R. L. Modlin, and S. A. Porcelli. 1996. CD1c restricts responses of mycobacteria-specific T cells: evidence for antigen presentation by a second member of the human CD1 family. J. Immunol. 157:2795.
12. Stenger, S., R. J. Mazzaccaro, K. Uyemura, S. Cho, P. F. Barnes, J. P. Rosat, A. Sette, M. B. Brenner. S. A. Porcelli, B. R. Bloom, and R. L. Modlin. 1997. Different effects of cytolytic T cell subsets on intracellular infection. Science 276:1684.
13. - α/β T cells demonstrates preferential use of several Vβ genes and an invariant TCR α chain. J. Exp. Med. 178:1.
14. - T cells. J. Exp. Med. 180:1171.
15. -T cells in mice and humans. J. Exp. Med. 180:1097.
16. + T lymphocytes. Science 268:863.
17. Bendelac, A., M. N. Rivera, S.-H. Park, and J. H. Roark. 1997. Mouse CD1-specific NKI T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535.
18. Smyth, M. J., K. Y. Thia, S. E. Street, E. Cretney, J. A. Trapani, M. Taniguchi, T. Kawano, S. B. Pelikan, N. Y. Crowe, and D. I. Godfrey. 2000. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 191:661.
19. Terabe, M., S. Matsui, N. Noben-Trauth, H. Chen, C. Watson, D. D. Donaldson, D. P. Carbone, W. E. Paul. and J. A. Berzofsky. 2000. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat. Immun. 1:515.
20. +-like thymocytes in the NOD mouse. Eur. J. Immunol. 26:2989.
21. Wilson, S. B., S. C. Kemt, K. T. Patton, T. Orban, R. A. Jackson, M. Exley, S. Porcelli, D. A. Schatz, M. A. Atkinson, S. P. Balk, et al. 1998. Extreme Th1 bias of invariant Vα24JαQ T cells in type I diabetes. Nature 391:177.
22. Dieli, F., G. Sireci, D. Russo, M. Taniguchi, J. Ivanyi, C. Fernandez, M. Troye-Blomberg, G. De Leo, and A. Salerno. 2000. Resistance of natural killer T cell-deficient mice to systemic Shwartzman reaction. J. Exp. Med. 192: 1645.
23. + T lymphocytes. Eur. J. Immunol. 27:183.
24. + TCR αβ intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro. J. Immunol. 164:1463.
25. Natori, T., M. Morita, K. Akimoto, and Y. Koezuka. 1994. Agelasphins, novel antitumor and immunostimulatory cerebrosides from the sponge Agelas mauritianus. Tetrahedron 50:2771.
26. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278:1626.
27. Brossay, L., M. Chioda, N. Burdin, Y. Koezuka, G. Casorati, P. Dellabona, and M. Kronenberg. 1998. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188:1521.
28. + NK T lymphocytes. J. Immunol. 161:3271.
29. Spada, F. M., Y. Koezuka, and S. A. Porcelli. 1998. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188:1529.
30. Joyce, S., A. S. Woods, J. W. Yewde1l, J. R. Bennink, D. De Silva, A. Boesteanu, S. P. Balk, R. J. Cotter, and R. R. Brutkiewicz. 1998. Natural ligand of mouse CD1dl: cellular glycosylphosphatidylinositol. Science 279:1541.
31. Schofield, L., M. J. McConville, D. Hansen, A. S. Campbell, B. Fraser-Reid, M. J. Grusby, and S., D. Tachado. 1999. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 283:225.
32. Molano, A., S. H. Park, Y.-H. Chiu, S. Nosseir, A. Bendelac, and M. Tsuji. 2000. Cutting edge: The IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and antimalarial responses. J. Immunol. 164:5005.
33. Romero, J. F., G. Eberl, H. R. MacDonald, and G. Corradin. 2001. CD1d-restricted NK T cells are dispensable for specific antibody responses and protective immunity against liver stage malaria infection in mice. Parasite Immunol. 23: 267.
34. Almeida, I. C., and R. T. Gazzinelli. 2001. Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analysis. J. Leukocyte Biol. 70:467.
35. Ropert, C., and R. T. Gazzinelli. 2000. Signaling of immune system cells by glycosylphosphatidylinositol (GPI) anchor and related structures derived from parasitic protozoa. Curr. Opin. Microbiol. 3:395.
36. Almeida, I. C., S. R. Milani, P. A. Gorin, and L. R. Travassos. 1991. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-α-galactosyl antibodies. J. Immunol. 146:2394.
37. Almeida, I. C., M. A. J. Ferguson, S. Schenkman, and L. R. Travassos. 1994. Lytic anti-α-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosylphosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi. Biochem. J. 304:793.
38. Pereira-Chioccola, V. L., A. Acosta-Serrano, I. C. Almeida, M. A. J. Ferguson, T. Souto-Padron, M. M. Rodrigues, L. R. Travassos, and S. Schenkman. 2000. Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-α-galactosyl antibodies. J. Cell Sci. 113:1299.
39. Golgher, D. B., W. Colli, T. Souto-Padron. and B. Zingales. 1993. Galactofuranose-containing glycoconjugates of epimastigote and trypomastigote forms of Trypanosoma cruzi. Mol. Biochem. Parasitol. 60:249.
40. Tourne, S., H. M. van Santen, M. van Roon, A. Berns, C. Benoist, D. Mathis, and H. Ploegh. 1996. Biosynthesis of major histocompatibility complex molecules and generation of T cells in li TAP1 double-mutant mice. Proc. Natl. Acad. Sci. USA 93:1464.
41. + intestinal intraepithelial lymphocytes in the absence of the both classical major histocompatibility complex class I and nonclassical CDI molecules. J. Exp. Med. 190:885.
42. Almeida. I. C., M. M. Camargo, D. O. Procopio. L. S. Silva, A. Mehler, L. R. Travassos, R. T. Gazzinelli, and M. A. J. Ferguson. 2000. Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. EMBO J. 19:1476.
43. Camargo, M. M., I. C. Almeida, M. E. Pereira, M. A. J. Ferguson, L. R. Travassos. and R. T. Gazzinelli. 1997. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. J. Immunol. 158:5890.
44. Ferguson. M. A. J. 1993. GPI-membrane anchors: isolation and analysis. In Glycobiology: a Practical Approach. M. Fukuda and A. Kobata, eds. Oxford University Press, New York, pp. 349-383.
45. Benlagha, K., A. Weiss, A. Beavis, L. Teyton. and A. Bendelac. 2000. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191:1895.
46. Gillis, S., M. M. Ferm, W. Ou, and K. A. Smith. 1978. T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120:2027.
47. Camargo, M. M., A. C. Andrade, I. C., Almeida, L. R. Travassos, and R. T. Gazzinelli. 1997. Glycoconjugates isolated from Trypanosoma cruzi but not from Leishmania species membranes trigger nitric oxide synthesis as well as microbicidal activity in IFN-γ-primed macrophages. J. Immunol. 159:6131.
48. Drapier, J. C., J. Wietzerbin, and J. B. Hibbs, Jr. 1988. Interferon-γ and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur. J. Immunol. 18:1587.
49. Julius, M. H., E. Simpson, and L. A. Herzenberg. 1973. A rapid method for the isolation of functional thymus-derived lymphocytes. Eur. J. Immunol. 3:6.
50. Abrahamsohn, I. A., and R. I. Coffman. 1985. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J. Immunol. 155: 3955.
51. Ropert, C., I. C. Almeida, M. Closel, L. R. Travassos, M. A. J. Ferguson, P. Cohen, and R. T. Gazzinelli. 2001. Requirement of mitogen-activated protein kinases and I-κB phosphorylation for induction of pro-inflammatory cytokines synthesis by macrophages indicates functional similarity of receptors triggered by glycosylphosphatidylinositol anchors from parasitic protozoa and bacterial LPS. J. Immunol. 166:3423.
52. Campos, M. A. S., I. C. Almeida, O. Takeuchi, S. Akira, E. P. Valente, D. O. Proc6pio, L. R. Travassos, J. A. Smith, D. T. Golenbock, and R. T. Gazzinelli. 2001. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from protozoan parasite. J. Immunol. 167:416.
53. + effector function against intracellular infection. J. Exp. Med. 184:131.
54. + Vα14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int. Immunol. 12:1267.
55. Gonzalez-Aseguinolaza, G., C. Oliveira, M. Tomaska, S. Hong, O. Bruna-Romero, T. Nakayama, M. Taniguchi, A. Bendelac, L. V. Kaer, Y. Koezuka, and M. Tsuji. 2000. α-Galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. USA 97:8461.
56. Di Noia, J. M., I. D'Orso, L. Aslund, D. O. Sanchez, and A. C. Frash. 1998. The Trypanosoma cruzi mucin family is transcribed from hundreds of genes having hypervariable regions. J. Biol. Chem. 273:10843.
57. Umezawa, E. S., M. A. Shikanai-Yasuda, A. Gruber, V. L. Pereira-Chioccola, and B. Zingales. 1996. Trypanosoma cruzi defined antigens in the serological evaluation of an outbreak of acute Chagas' disease in Brazil (Catole do Rocha. Paraiba). Mem. Inst. Oswaldo Cruz. 91:87.
58. Porcelli, S. A., and M. B. Brenner. 1997. Antigen presentation: mixing oil and water. Curr. Biol. 7:R508.
59. Gumperz, J. E., C. Roy, A. Makowska, D. Lum, M. Sugita, T. Podrebarac, Y. Koezuka, S. A. Porcelli, S. Cardell, M. B. Brenner, and S. M. Behar. 2000. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12:211.
60. Bento, C. A., M. B. Melo, J. O. Previato, L. Mendonca-Previato, and L. M. Pecanha. 1996. Glycoinositolphospholipids purified from Trypanosoma cruzi stimulate Ig production in vitro. J. Immunol. 157:4996.
61. Bilate, A. M., J. O. Previato, L. Mendonça-Previato, and L. M. Peçanha. 2000. Glycoinositolphospholipids from Trypanosoma cruzi induce B cell hyper-responsiveness in vivo. Glycoconj. J. 17:727.
62. Duthie, M. S., M. Wleklinski-Lee, S. Smith, T. Nakayama, M. Taniguchi, and S. J. Stuart. 2001. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein. Infect. Immun. 70:36.